In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):535-6. doi: 10.1097/01.qai.0000194735.66322.d9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adolescent
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasms / chemically induced
  • Neoplasms / epidemiology*
  • Neoplasms / etiology
  • Pregnancy
  • Pregnancy Complications
  • Prenatal Exposure Delayed Effects*
  • Reverse Transcriptase Inhibitors / adverse effects
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Statistics as Topic

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors